Stay updated on Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial
Sign up to get notified when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.

Latest updates to the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page
- CheckyesterdayChange DetectedThe page now includes a recruitment status update 'No longer looking for participants.' It adds new guidance sections 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study,' and the revision note updates from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check8 days agoChange DetectedRevision tag changed from v3.5.4 to v3.5.5, indicating a minor update to the page metadata. This update does not appear to modify the study content or user-facing information.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a software version update for the site. This change does not modify the displayed study content or its results.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a change to the site build rather than the clinical trial information shown to users.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check73 days agoChange DetectedPosted trial results and updated study record dates were added to the page (Results First Posted 2024-11-14; Study Record Dates Updated 2024-11-14).SummaryDifference0.0%

Stay in the know with updates to Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.